Barco announced the debut of its 12 million-pixel Coronis Uniti display system at the 73rd spring China International Medical Equipment Fair (CMEF), held in Shanghai in May 2015. Barco also introduced a full range of LED medical displays.
On June 16, 2015, William Beaumont Hospital and Elekta Ltd. filed a patent infringement suit against Varian Medical Systems Inc. in the United States District Court for the Eastern District of Michigan.
Carestream and UBMD Orthopedics & Sports Medicine are conducting clinical studies on a new three-dimensional medical imaging system at the Erie County Medical Center (ECMC) for use in treating orthopedic conditions. These studies will help guide Carestream’s development of new cone beam computed tomography (CBCT) systems with the goal of providing orthopedic solutions for hospitals, clinics and sports medicine providers that use less radiation than traditional CT; are compact and affordable; and could be used in a wide range of facilities.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Agfa HealthCare announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for diagnostic viewing with the XERO Viewer. This Full Fidelity View functionality of the viewer uses lossless compression to provide diagnostic quality when images are displayed, by retrieving original-quality renditions of stored digital X-ray (DX), computed tomography (CT), magnetic resonance imaging (MRI), computed radiography (CR) and ultrasound (US) images.
Pie Medical Imaging announced its new release of CAAS MRV, for analysis of the heart to support diagnosis of cardiovascular conditions. This new version contains intuitive and guided analysis workflows, optimized to clinical practice. The workflows guide users through the required steps for functional left and right ventricle, viability and first pass perfusion analysis. The new viability workflow includes, besides analysis of delayed enhanced MR (magnetic resonance) images, also analysis of edema on T2-weighted MR images. The combination of segmented infarcts and edema areas can identify the salvageable areas.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
GE Healthcare announced the launch of its new introductory dose management solution, DoseWatch Explore, which is now available on select GE computed tomography (CT) systems in the United States. DoseWatch Explore is a Web-based, cloud-deployed, dose management software that tracks, analyzes and reports practice-level radiation dose data for GE CT systems.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Calgary Scientific Inc. announced the release of ResolutionMD 5.1. The latest software version enables physicians to make faster and more informed treatment decisions, by providing even greater access to medical images and information via Web and mobile devices.
A new magnetic resonance imaging (MRI) study has found distinct injury patterns in the brains of people with concussion-related depression and anxiety, according to a new study published online in the journal Radiology. The findings may lead the way to improved treatment and understanding of these common disorders, researchers said.
IMRIS Inc. received a letter May 26 from the NASDAQ Stock Market stating that it would be delisted and trading suspended on June 4. IMRIS said this was in accordance with Listing Rules 5101, 5110(b), and IM-5101-1. A Form 25-NSE will be filed with the Securities and Exchange Commission (the SEC), which will remove the company's securities from listing and registration on The Nasdaq Stock Market.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Toshiba America Medical Systems Inc. has received U.S. Food and Drug Administration (FDA) clearance for detector and computed tomography (CT) software enhancements for its Aquilion ONE family of CT systems. which are designed to offer customers the right technology to meet their business needs for improving patient safety, have received FDA clearance.
Richardson Electronics, Ltd. today announced the signing of a definitive agreement to acquire the assets of International Medical Equipment and Service, Inc. (IMES). IMES is the first acquisition completed by Richardson Healthcare, the division of Richardson Electronics focused on high-value components and replacement parts for the diagnostic imaging market.
​Carestream Health will show a model of its cone beam CT (CBCT) system at AHRA that is currently undergoing clinical studies and is being designed to: provide weight-bearing images of knees, legs and feet as well as other orthopaedic exams; use less radiation than traditional CT; and be used in a wide range of facilities. This CBCT system is INVESTIGATIONAL and NOT AVAILABLE FOR COMMERCIAL SALE. Carestream is also demonstrating its new Touch Ultrasound platform that received 510(k) Clearance and is available for sale in the United States and its advanced healthcare IT solutions including PACS, vendor-neutral archive, Clinical Collaboration Platform and Carestream’s Vue Motion enterprise viewer.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
vRad (Virtual Radiologic), a leading telemedicine company and radiology practice, and MetaMind, Inc., a provider of state-of-the-art Artificial Intelligence (AI) solutions powered by “deep learning,†announced a partnership to improve the speed, accuracy and quality of radiology diagnostics for a series of potentially life-threatening conditions, the first of which will be intracranial hemorrhaging (IH). IH (blood leaking inside the brain) requires immediate medical treatment, otherwise it quickly leads to increased pressure in the brain, and potentially damaged brain tissue or death.
Together with its customers, Elekta raised EUR 30,575 (USD 33,250) during the 3rd European Society for Therapeutic Radiology and Oncology (ESTRO) Forum in Barcelona in April. The funds will be donated to Radiating Hope, a nonprofit organization with the mission to improve cancer care, specifically radiation oncology care, around the world.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
iCAD Inc. announced the first Xoft Axxent Electronic Brachytherapy (eBx) System in Spain is now available at the Hospital Miguel Servet for the treatment of early-stage breast cancer, non-melanoma skin cancer and gynecological cancers. iCAD highlighted the Xoft System at the third European Society for Radiotherapy and Oncology (ESTRO) Forum in Barcelona, April 24-28.
Role of Interventional Echcardiography in Transcatheter Structural Heart Procedures — Rebecca Hahn, M.D., Columbia ...
In March, Apple announced the launch of ResearchKit, an open source software framework designed for medical and health research. The platform is designed to help doctors and scientists gather data more frequently and more accurately from participants using iPhone apps. World-class research institutions have already developed apps with ResearchKit for studies on asthma, breast cancer, cardiovascular disease, diabetes and Parkinson’s disease. Users decide if they want to participate in a study and how their data is shared.
Four studies evaluating effectiveness, trends and other considerations for active surveillance in managing prostate cancer were presented during the 110th annual scientific meeting of the American Urological Association (AUA). Stacy Loeb, M.D., assistant professor of urology at New York University, moderated the session.
IBA (Ion Beam Applications S.A.) announced the successful completion of its fifth IBA Academy on the Road enhanced training workshop. This, and several other training offerings, are key cornerstones of the IBA CAREprogram initiative, which allows close partnering with IBA customers for optimized user satisfaction.
The prostate-specific membrane antigen (PSMA) biomarker is the bullseye for three new magnetic resonance imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types. The agents were discussed in research unveiled at the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).